PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
1-Year Return
73.17%
This Quarter Return
+18.66%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.23B
AUM Growth
+$120M
(+11%)
Cap. Flow
+$14.7M
Cap. Flow
% of AUM
1.2%
Top 10 Holdings %
Top 10 Hldgs %
49.61%
Holding
221
New
48
Increased
36
Reduced
31
Closed
51
Top Buys
| 1 |
NXTM
NxStage Medical Inc.
NXTM
|
$30M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$25.3M |
| 3 |
STJ
St Jude Medical
STJ
|
$18.2M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$15.1M |
| 5 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$10.1M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$41.5M |
| 2 |
Humana
HUM
|
$20.1M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$11.8M |
| 4 |
Baxter International
BAX
|
$9.04M |
| 5 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$7.9M |
Sector Composition
| 1 | Healthcare | 89.18% |
| 2 | Consumer Discretionary | 0.09% |
| 3 | Consumer Staples | 0.05% |
| 4 | Financials | 0.04% |
| 5 | Industrials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STML
101
DELISTED
Stemline Therapeutics, Inc.
STML
| $532K | 0.04% |
78,603
| – | – |
|
102
Labcorp
LH
$22.9B
| $520K | 0.04% |
+4,644
| New | +$520K |
|
103
Cencora
COR
$56.7B
| $516K | 0.04% |
+6,500
| New | +$516K |
|
104
Spyre Therapeutics
SYRE
$1.03B
| $515K | 0.04% |
+4,236
| New | +$515K |
|
|
IMMU
105
DELISTED
Immunomedics Inc
IMMU
| $514K | 0.04% |
221,700
-1,198,300
| -84% | -$2.78M |
|
|
AFAM
106
DELISTED
Almost Family Inc
AFAM
| $509K | 0.04% |
11,942
-1,133
| -9% | -$48.3K |
|
107
United Therapeutics
UTHR
$17.2B
| $503K | 0.03% |
4,753
-15,247
| -76% | -$1.61M |
|
108
Cardinal Health
CAH
$35.7B
| $499K | 0.03% |
6,398
+451
| +8% | +$35.2K |
|
|
CGNT
109
DELISTED
Cogentix Medical, Inc.
CGNT
| $498K | 0.03% |
517,760
-155,497
| -23% | -$150K |
|
110
HCA Healthcare
HCA
$96.3B
| $478K | 0.03% |
6,202
-984
| -14% | -$75.8K |
|
|
KND
111
DELISTED
Kindred Healthcare
KND
| $478K | 0.03% |
+42,301
| New | +$478K |
|
112
Molina Healthcare
MOH
$9.26B
| $459K | 0.03% |
9,200
+1,148
| +14% | +$57.3K |
|
113
UnitedHealth
UNH
$281B
| $456K | 0.03% |
3,231
-1,115
| -26% | -$157K |
|
114
Phibro Animal Health
PAHC
$1.58B
| $453K | 0.03% |
+24,300
| New | +$453K |
|
115
Charles River Laboratories
CRL
$7.99B
| $452K | 0.03% |
5,482
-762
| -12% | -$62.8K |
|
|
SCMP
116
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $451K | 0.03% |
41,096
+40,337
| +5,314% | +$443K |
|
117
Tenet Healthcare
THC
$17B
| $448K | 0.03% |
+16,200
| New | +$448K |
|
118
Elevance Health
ELV
$69.4B
| $447K | 0.03% |
3,400
-347
| -9% | -$45.6K |
|
|
ISEE
119
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $416K | 0.03% |
+8,145
| New | +$416K |
|
|
ENZ
120
DELISTED
Enzo Biochem, Inc.
ENZ
| $401K | 0.03% |
+67,113
| New | +$401K |
|
121
SCYNEXIS
SCYX
$36.4M
| $380K | 0.03% |
17,500
| – | – |
|
122
Stellantis
STLA
$26.2B
| $379K | 0.03% |
62,248
-311
| -0.5% | -$1.89K |
|
123
Centene
CNC
$14.1B
| $353K | 0.02% |
9,896
| – | – |
|
|
GRCE
124
Grace Therapeutics, Inc. Common Stock
GRCE
$42.3M
| $336K | 0.02% |
4,928
| – | – |
|
125
Intellia Therapeutics
NTLA
$1.25B
| $320K | 0.02% |
+15,000
| New | +$320K |
|